Rimexolone ophthalmic Pregnancy and Breastfeeding Warnings

Rimexolone ophthalmic is also known as: Vexol

Rimexolone ophthalmic Pregnancy Warnings

Rimexolone ophthalmic suspension has been assigned to pregnancy category C by the FDA. Animal data have revealed evidence of teratogenicity and embryotoxicity following subcutaneous administration of a dose approximately twice the recommended human ophthalmic dose. There are no controlled data in human pregnancy. Rimexolone should only be given during pregnancy when benefit outweighs risk.

Rimexolone ophthalmic Breastfeeding Warnings

There are no data on the excretion of rimexolone into human milk. Rimexolone is absorbed systemically after ocular administration, resulting in average serum concentrations of 130 pg/mL. The manufacturer recommends that a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.

Hide
(web4)